Abstract
Exposure of streptomycin-resistant cells to puromycin results in uptake of dihydrostreptomycin comparable to that found with streptomycin-sensitive cells. This finding indicates that the enhanced phase of uptake, previously reported only in sensitive cells, may result from an increase in internal binding sites, presumably run-off ribosomes. The increased uptake of dihydrostreptomycin resulting from exposure to puromycin is greatest in both sensitive and resistant cells at concentrations below 100 microgram/ml. At 100 microgram/ml, exposure to puromycin in vivo results in significant, but not complete, polysome degradation and inhibition of protein synthesis. At 500 microgram/ml, where polysome degradation is complete in less than 2 min and where growth and protein synthesis are inhibited more than 90%, uptake of dihydrostreptomycin by both sensitive and resistant cells is inhibited. Puromycin has no effect on binding of dihydrostreptomycin to 70-S monosomes, as measured by equilibrium dialysis. The increased uptake of dihydrostreptomycin by resistant cells resulting from exposure to puromycin has no effect on viability. Addition of N-ethylmaleimide immediately and completely inhibits the puromycin-induced uptake of dihydrostrep...Continue Reading
References
Aug 1, 1977·Antimicrobial Agents and Chemotherapy·L E Bryan, H M Van Den Elzen
May 16, 1978·European Journal of Biochemistry·J V Höltje
Feb 1, 1979·Antimicrobial Agents and Chemotherapy·J V Höltje
Jun 1, 1976·Antimicrobial Agents and Chemotherapy·L E Bryan, H M Van den Elzen
May 1, 1975·Antimicrobial Agents and Chemotherapy·P DionneC Hurwitz
Oct 1, 1972·Antimicrobial Agents and Chemotherapy·F N Chang, J G Flaks
Oct 1, 1972·Antimicrobial Agents and Chemotherapy·F N Chang, J G Flaks
Oct 11, 1974·Nature·K Andry, R C Bockrath
Oct 28, 1969·Journal of Molecular Biology·C GurgoD Schlessinger
Apr 5, 1973·Journal of Molecular Biology·B J Wallace, B D Davis
Jan 1, 1971·Annual Review of Microbiology·S Pestka
Aug 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·E Z RonB D Davis
Oct 25, 1969·Nature·J Modolell, B D Davis
Jan 2, 1960·Nature·N ANANDA K ARMITAGE
May 9, 1964·Nature·J ARONSONT D BROCK
Jun 1, 1962·Journal of Bacteriology·C HURWITZ, C L ROSANO
Jun 1, 1962·Journal of Bacteriology·C HURWITZ, C L ROSANO
Feb 1, 1948·Journal of Bacteriology·R E Horne, A L Pollard
Citations
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·B D DavisP C Tai
Jun 1, 1983·Antimicrobial Agents and Chemotherapy·L E Bryan, S Kwan
Oct 1, 1984·Antimicrobial Agents and Chemotherapy·L J MandelM H Miller
Apr 1, 1990·Antimicrobial Agents and Chemotherapy·M A Wyka, A C St John
Dec 26, 2001·Journal of Bacteriology·Mary V MawnThomas L Mason
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·N E AllenH A Kirst
Sep 14, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maria S Ramirez, Marcelo E Tolmasky
Apr 7, 2017·Molecular Microbiology·Marion HerisseBenjamin Ezraty
Jan 1, 1987·Biochimica Et Biophysica Acta·W W Nichols
Jun 2, 2005·Biotechnology Letters·Snehasis Jana, J K Deb
Dec 20, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria S Ramirez, Marcelo E Tolmasky
Aug 24, 2018·Antibiotics·Frédéric BarrasBenjamin Ezraty
Oct 23, 2019·Journal of Biomolecular Structure & Dynamics·Dhamodharan PrabhuJeyaraman Jeyakanthan
Aug 22, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·E Azucena, S Mobashery
Jan 1, 1988·Clinical Microbiology Reviews·D Schlessinger
Dec 1, 1987·Microbiological Reviews·H W TaberA S Arrow
Nov 1, 2012·ACS Chemical Biology·Bernd Becker, Matthew A Cooper